Jan D. Lünemann

11.5k total citations
127 papers, 5.5k citations indexed

About

Jan D. Lünemann is a scholar working on Immunology, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, Jan D. Lünemann has authored 127 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Immunology, 38 papers in Neurology and 37 papers in Pathology and Forensic Medicine. Recurrent topics in Jan D. Lünemann's work include Multiple Sclerosis Research Studies (28 papers), T-cell and B-cell Immunology (28 papers) and Peripheral Neuropathies and Disorders (27 papers). Jan D. Lünemann is often cited by papers focused on Multiple Sclerosis Research Studies (28 papers), T-cell and B-cell Immunology (28 papers) and Peripheral Neuropathies and Disorders (27 papers). Jan D. Lünemann collaborates with scholars based in Germany, Switzerland and United States. Jan D. Lünemann's co-authors include Christian Münz, Christian W. Keller, Isaak Quast, Falk Nimmerjahn, Marinos C. Dalakas, Björn Tackenberg, Roland Martinꝉ, Kristina Kakalacheva, Meghann Teague Getts and Stephen D. Miller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Jan D. Lünemann

116 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan D. Lünemann Germany 40 2.3k 1.7k 1.2k 1.0k 1.0k 127 5.5k
Thomas Leist United States 39 2.1k 0.9× 1.7k 1.0× 790 0.6× 656 0.6× 860 0.8× 124 4.9k
Sachiko Miyake Japan 56 5.8k 2.5× 1.3k 0.8× 3.1k 2.5× 687 0.7× 1.4k 1.4× 152 10.0k
Ricardo Pujol‐Borrell Spain 42 4.4k 1.9× 531 0.3× 1.2k 0.9× 644 0.6× 928 0.9× 181 8.4k
D. E. McFarlin United States 34 3.0k 1.3× 1.3k 0.7× 1.3k 1.0× 575 0.6× 720 0.7× 79 5.1k
Olivier Boyer France 43 1.6k 0.7× 360 0.2× 1.9k 1.5× 1.9k 1.8× 772 0.8× 177 5.9k
Marco W.J. Schreurs Netherlands 41 2.2k 1.0× 296 0.2× 1.4k 1.1× 1.1k 1.0× 1.1k 1.1× 172 6.2k
William J. Karpus United States 39 3.8k 1.6× 1.0k 0.6× 929 0.7× 403 0.4× 1.9k 1.9× 73 6.1k
Su-Ming Hsu United States 33 1.2k 0.5× 1.2k 0.7× 1.5k 1.2× 497 0.5× 1.5k 1.5× 74 5.5k
Sandra D’Alfonso Italy 32 1.7k 0.7× 496 0.3× 970 0.8× 539 0.5× 435 0.4× 135 4.4k
Jane H. Buckner United States 55 7.2k 3.1× 608 0.4× 2.0k 1.6× 692 0.7× 1.4k 1.4× 188 11.8k

Countries citing papers authored by Jan D. Lünemann

Since Specialization
Citations

This map shows the geographic impact of Jan D. Lünemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan D. Lünemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan D. Lünemann more than expected).

Fields of papers citing papers by Jan D. Lünemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan D. Lünemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan D. Lünemann. The network helps show where Jan D. Lünemann may publish in the future.

Co-authorship network of co-authors of Jan D. Lünemann

This figure shows the co-authorship network connecting the top 25 collaborators of Jan D. Lünemann. A scholar is included among the top collaborators of Jan D. Lünemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan D. Lünemann. Jan D. Lünemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eveslage, Maria, Andreas Schulte‐Mecklenbeck, Catharina C. Groß, et al.. (2025). Suboptimal B-cell depletion is associated with progression independent of relapse activity in multiple sclerosis patients treated with ocrelizumab. Multiple Sclerosis Journal. 31(7). 813–820.
2.
Zobel, Thomas, et al.. (2025). ATG5 controls CD80 expression in B cells and shapes cognate CD4 + T cell responses. Autophagy. 21(10). 2284–2292.
3.
Gerischer, Lea, Frauke Stascheit, Philipp Mergenthaler, et al.. (2025). Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab. Annals of Clinical and Translational Neurology.
4.
Stascheit, Frauke, Annette Aigner, Christian W. Keller, et al.. (2024). Ravulizumab and Efgartigimod in Myasthenia Gravis. Neurology Neuroimmunology & Neuroinflammation. 12(1). e200331–e200331. 5 indexed citations
5.
Stascheit, Frauke, Christian W. Keller, Maja Pučić‐Baković, et al.. (2024). Functional Signature of LRP4 Antibodies in Myasthenia Gravis. Neurology Neuroimmunology & Neuroinflammation. 11(3). e200220–e200220. 9 indexed citations
6.
Keller, Christian W., Iannis E. Adamopoulos, & Jan D. Lünemann. (2023). Autophagy pathways in autoimmune diseases. Journal of Autoimmunity. 136. 103030–103030. 39 indexed citations
7.
Baumgarten, Louisa von, Hans J. Stauss, & Jan D. Lünemann. (2023). Synthetic Cell-Based Immunotherapies for Neurologic Diseases. Neurology Neuroimmunology & Neuroinflammation. 10(5). 8 indexed citations
8.
Comabella, Manuel, Mar Tintoré, Augusto Sao Avilés, et al.. (2022). Increased cytomegalovirus immune responses at disease onset are protective in the long-term prognosis of patients with multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 94(3). 173–180. 7 indexed citations
9.
Keller, Christian W., Joseph A. Lopez, Eva‐Maria Wendel, et al.. (2021). Complement Activation Is a Prominent Feature of MOGAD. Annals of Neurology. 90(6). 976–982. 35 indexed citations
10.
Keller, Christian W., Marc Pawlitzki, Heinz Wiendl, & Jan D. Lünemann. (2021). Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis. International Journal of Molecular Sciences. 22(11). 5755–5755. 16 indexed citations
11.
Keller, Christian W., Christian Münz, & Jan D. Lünemann. (2020). Autophagy Pathways in CNS Myeloid Cell Immune Functions. Trends in Neurosciences. 43(12). 1024–1033. 10 indexed citations
12.
Lünemann, Jan D., Tobias Ruck, Paolo A. Muraro, Amit Bar‐Or, & Heinz Wiendl. (2020). Author Correction: Immune reconstitution therapies: concepts for durable remission in multiple sclerosis. Nature Reviews Neurology. 16(2). 125–125. 4 indexed citations
13.
Caduff, Nicole, Donal McHugh, Anita Murer, et al.. (2020). Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice. PLoS Pathogens. 16(4). e1008477–e1008477. 16 indexed citations
14.
Lünemann, Jan D., Tobias Ruck, Paolo A. Muraro, Amit Bar‐Or, & Heinz Wiendl. (2019). Immune reconstitution therapies: concepts for durable remission in multiple sclerosis. Nature Reviews Neurology. 16(1). 56–62. 67 indexed citations
15.
Keller, Christian W., Sarah Mundt, Isaak Quast, et al.. (2017). ATG-dependent phagocytosis in dendritic cells drives myelin-specific CD4 + T cell pathogenicity during CNS inflammation. Proceedings of the National Academy of Sciences. 114(52). E11228–E11237. 65 indexed citations
16.
Schneider, Christoph, Christian W. Keller, Isaak Quast, et al.. (2017). IVIG regulates the survival of human but not mouse neutrophils. Scientific Reports. 7(1). 1296–1296. 28 indexed citations
17.
Keller, Christian W., Jens Schmidt, & Jan D. Lünemann. (2017). Immune and myodegenerative pathomechanisms in inclusion body myositis. Annals of Clinical and Translational Neurology. 4(6). 422–445. 40 indexed citations
18.
Keller, Christian W., Stuart Turville, Anna Lünemann, et al.. (2010). TNF-α Induces Macroautophagy and Regulates MHC Class II Expression in Human Skeletal Muscle Cells. Journal of Biological Chemistry. 286(5). 3970–3980. 101 indexed citations
19.
Comabella, Manuel, Xavier Montalbán, Christian Münz, & Jan D. Lünemann. (2010). Targeting dendritic cells to treat multiple sclerosis. Nature Reviews Neurology. 6(9). 499–507. 59 indexed citations
20.
Lünemann, Jan D., Hans Gelderblom, Mireia Sospedra, et al.. (2006). Cerebrospinal Fluid-Infiltrating CD4 + T Cells Recognize Borrelia burgdorferi Lysine-Enriched Protein Domains and Central Nervous System Autoantigens in Early Lyme Encephalitis. Infection and Immunity. 75(1). 243–251. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Leist Breakdown of academic impact, for papers by Sachiko Miyake Breakdown of academic impact, for papers by Ricardo Pujol‐Borrell Breakdown of academic impact, for papers by D. E. McFarlin Breakdown of academic impact, for papers by Olivier Boyer Breakdown of academic impact, for papers by Marco W.J. Schreurs Breakdown of academic impact, for papers by William J. Karpus Breakdown of academic impact, for papers by Su-Ming Hsu Breakdown of academic impact, for papers by Sandra D’Alfonso Breakdown of academic impact, for papers by Jane H. Buckner
Rankless by CCL
2026